Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aims of this observational study are to identify the primary BPH symptoms responsible for
the patients to consult a urologic practice, resulting in the prescription of ALNA®, to
assess the clincial efficacy on an improved occupational performance of the patients being
still employed. Additionally to obtain relevant information for the 5-year report of
experience with this product according to the requirements in § 49, para 6 of the German
Medicines Act.